1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-methoxycarbonylpyridine-5-carboxylic acid 6-[5-(3,4-methylenedioxyphenyl)-3-pyrazolyloxy]hexyl ester | 86419-03-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 英文名称: 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-methoxycarbonylpyridine-5-carboxylic acid 6-[5-(3,4-methylenedioxyphenyl)-3-pyrazolyloxy]hexyl ester
• 英文别名: 5-O-[6-[[5-(1,3-benzodioxol-5-yl)-1H-pyrazol-3-yl]oxy]hexyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
• CAS: 86419-03-6
• 化学式: C₃₂H₃₄N₄O₉
• 分子量: 618.643
• InChiKey: AGZQONGCYKPINQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  45
• 可旋转键数：
  14
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.34
• 拓扑面积：
  167
• 氢给体数：
  2
• 氢受体数：
  11

反应信息

• 作为产物：
  描述：

  1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-methoxycarbonylpyridine-5-carboxylic acid 6-tosyloxyhexyl ester 、 3-(1,3-Benzodioxol-5-yl)-1,4-dihydropyrazol-5-one 生成 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-methoxycarbonylpyridine-5-carboxylic acid 6-[5-(3,4-methylenedioxyphenyl)-3-pyrazolyloxy]hexyl ester
  参考文献：
  名称：

  KAMIBAYASHI, MASATO;TSUCHIYA, SHINJI;HIRATSUKA, KOZO;TSUCHIYA, SUSUMU

  摘要：

  DOI：

文献信息

• 1,4-Dihydropyridine derivatives
  申请人：Tokyo Tanabe Company, Limited

  公开号：US04418197A1

  公开（公告）日：1983-11-29

  Novel 1,4-dihydropyridine derivatives of the formula [I] are provided: ##STR1## wherein R.sup.1 represents a C.sub.1-4 alkyl group or a C.sub.3-6 alkoxyalkyl group, R.sup.2 represents hydrogen or halogen, R.sup.3 is either nitro when R.sup.2 is hydrogen, or halogen when R.sup.2 is halogen, R.sup.4 represents a pyridyl group, a phenethyl group, an unsubstituted benzyl group, a substituted benzyl group having one or more suitable substituents, an unsubstituted phenyl group, or a substituted phenyl group having one or more suitable substituents, and A represents an unsubstituted hexamethylene group or a substituted hexamethylene group having one or two C.sub.1-3 alkyl groups. The 1,4-dihydropyridine derivatives have vasodilating and hypotensive activity which is kept for a long period, and are useful in the treatment of cardiovascular disease and hypertension.

  提供了式[I]的新型1,4-二氢吡啶衍生物：##STR1## 其中，R.sup.1代表C.sub.1-4烷基或C.sub.3-6烷氧基烷基，R.sup.2代表氢或卤素，当R.sup.2为氢时，R.sup.3为硝基，当R.sup.2为卤素时，R.sup.3为卤素，R.sup.4代表吡啶基，苯乙基，未取代苄基，具有一个或多个适当取代基的取代苄基，未取代苯基或具有一个或多个适当取代基的取代苯基，A代表未取代的六亚甲基或具有一个或两个C.sub.1-3烷基的取代六亚甲基。1,4-二氢吡啶衍生物具有扩血管和降压活性，该活性长时间保持，并且在心血管疾病和高血压的治疗中有用。
• US4418197A
  申请人：——

  公开号：US4418197A

  公开（公告）日：1983-11-29